APPLICATION
ANDA071071
TYPE
ANDA
ORIGINAL APPROVAL
1986-11-03
LATEST ACTION
1998-02-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
HALOPERIDOLDiscontinued
HALOPERIDOL 0.5MG · TABLET · ORAL
Approval history
1998-02-20Labeling · Supplement 4AP
1991-05-09Labeling · Supplement 9AP
1989-04-19Labeling · Supplement 8AP
1986-11-03OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.